SCHEMBL3781935

SCHEMBL3781935

O=S(=O)(Nc1ccc(NS(=O)(=O)c2ccccc2)c(Cl)c1)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 2/20 0.62
CRHR2 Q13324 2/20 0.62
GAA P10253 3/20 0.62
GFER P55789 1/20 0.62
APOBEC3G Q9HC16 1/20 0.62
LMNA P02545 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
ALDH1A1 P00352 3/20 0.58
PKM P14618 2/20 0.58
KEAP1 Q14145 2/20 0.57
HTR6 P50406 1/20 0.57
ERBB2 P04626 1/20 0.56
HSP90AA1 P07900 1/20 0.56
HSP90AB1 P08238 1/20 0.56
IL1RN P18510 1/20 0.56
ERAP1 Q9NZ08 1/20 0.56
ALOX15 P16050 2/20 0.56
HSD17B10 Q99714 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3780986 0.87 GAA (0.67) CRHBPCRHR2GAAGFERAPOBEC3G
SCHEMBL5163794 0.86 LMNA (0.62) GAAGFERAPOBEC3GLMNASMN1; SMN2
SCHEMBL11027219 0.85 ERBB2 (0.71) CRHBPCRHR2GAALMNAMEN1
SCHEMBL8307085 0.83 CRHBP (0.62) CRHBPCRHR2GAAMEN1KMT2A
SCHEMBL14679076 0.83 MEN1 (0.66) LMNASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL7170804 0.82 ERBB2 (0.63) CRHBPCRHR2GAAGFERAPOBEC3G
SCHEMBL7523467 0.82 HSD17B3 (0.73) GAAGFERAPOBEC3GLMNASMN1; SMN2
SCHEMBL22315132 0.82 MEN1 (0.67) CRHBPCRHR2GAAMEN1KMT2A
SCHEMBL2073110 0.82 CRHBP (0.61) CRHBPCRHR2GAAMEN1KMT2A
SCHEMBL8976245 0.82 PKM (0.67) GAALMNASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 CRHBP 3514/4885CRHR2 3773/4885GAA 1755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.